Bobby Gaspar

1.3k total citations
9 papers, 53 citations indexed

About

Bobby Gaspar is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Bobby Gaspar has authored 9 papers receiving a total of 53 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 4 papers in Hematology and 4 papers in Genetics. Recurrent topics in Bobby Gaspar's work include Virus-based gene therapy research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Bobby Gaspar is often cited by papers focused on Virus-based gene therapy research (3 papers), Immunodeficiency and Autoimmune Disorders (3 papers) and Autoimmune and Inflammatory Disorders Research (3 papers). Bobby Gaspar collaborates with scholars based in United Kingdom, United States and Germany. Bobby Gaspar's co-authors include Fani Ladomenou, Kimberly Gilmour, Maurice B. Loughrey, Shahnaz Bibi, Cathal Steele, Sandra Ammann, Emma Morris, Lisa Devlin, Adrian J. Thrasher and Ángeles Montero and has published in prestigious journals such as Blood, Molecular Therapy and Human Gene Therapy.

In The Last Decade

Bobby Gaspar

9 papers receiving 53 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bobby Gaspar United Kingdom	4	25	19	17	11	10	9	53
Ana Maria Van Den Rym Spain	5	49 2.0×	12 0.6×	24 1.4×	13 1.2×	9 0.9×	7	104
Nurhan Kasap Türkiye	7	47 1.9×	21 1.1×	10 0.6×	8 0.7×	9 0.9×	15	79
Rosaria Prencipe Italy	6	61 2.4×	19 1.0×	31 1.8×	10 0.9×	7 0.7×	8	100
Torstein Øverland Norway	4	57 2.3×	22 1.2×	20 1.2×	11 1.0×	8 0.8×	5	80
Anna Roppelt Russia	5	43 1.7×	12 0.6×	14 0.8×	20 1.8×	18 1.8×	22	80
Tala Shahin Austria	3	76 3.0×	19 1.0×	12 0.7×	8 0.7×	15 1.5×	5	88
Miriam Casiraghi Italy	4	36 1.4×	44 2.3×	29 1.7×	10 0.9×	25 2.5×	4	89
Claire Searle United Kingdom	4	10 0.4×	26 1.4×	28 1.6×	6 0.5×	8 0.8×	8	66
S. Kawai Japan	4	34 1.4×	17 0.9×	13 0.8×	11 1.0×	19 1.9×	7	85
Hasan Kapaklı Türkiye	4	39 1.6×	18 0.9×	13 0.8×	4 0.4×	8 0.8×	9	60

Countries citing papers authored by Bobby Gaspar

Since Specialization

Citations

This map shows the geographic impact of Bobby Gaspar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bobby Gaspar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bobby Gaspar more than expected).

Fields of papers citing papers by Bobby Gaspar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bobby Gaspar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bobby Gaspar. The network helps show where Bobby Gaspar may publish in the future.

Co-authorship network of co-authors of Bobby Gaspar

This figure shows the co-authorship network connecting the top 25 collaborators of Bobby Gaspar. A scholar is included among the top collaborators of Bobby Gaspar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bobby Gaspar. Bobby Gaspar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Jost, Philipp J., et al.. (2017). Gene therapy for X-linked Inhibitor of Apoptosis Protein (XIAP) deficiency. Human Gene Therapy. 28. 1 indexed citations

2.

Ladomenou, Fani & Bobby Gaspar. (2016). How to use immunoglobulin levels in investigating immune deficiencies. Archives of Disease in Childhood Education & Practice. 101(3). 129–135. 13 indexed citations

3.

Schwarzer, Adrian, Steven R. Talbot, Oliver Dittrich‐Breiholz, et al.. (2016). New Molecular Surrogate Assay for Genotoxicity Assessment of Gene Therapy Vectors (SAGA). Blood. 128(22). 4710–4710. 4 indexed citations

4.

Steele, Cathal, Sandra Ammann, Maurice B. Loughrey, et al.. (2016). X-linked Inhibitor of Apoptosis Complicated by Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) and Granulomatous Hepatitis. Journal of Clinical Immunology. 36(7). 733–738. 16 indexed citations

5.

Tiwari, Swati, Catherine E. Terrell, Paritha Arumugam, et al.. (2015). 237. Genetic Therapy for Perforin Deficiency Associated Hemophagocytic Lymphohistiocytosis Requires High Level Expression of the Perforin Gene for Adequate Correction. Molecular Therapy. 23. S93–S93. 1 indexed citations

6.

Jordan, Michael B., Marlene Carmo, Swati Tiwari, et al.. (2012). Gene Therapy for Hemophagocytic Lymphohistiocytosis (HLH): Fixing a Criticial ‘Circuit Breaker’ in the Immune System.. Blood. 120(21). 3158–3158. 1 indexed citations

7.

Korthof, Elisabeth T, Martine F. Raphaël, Dorine Bresters, et al.. (2011). Dyskeratosis Congenita: Evaluation of Immune Status and Hematopoietic Stem Cell Transplantation. A Literature and EBMT Data Base Survey of 75 Patients,. Blood. 118(21). 4144–4144. 1 indexed citations

8.

Thrasher, Adrian J., et al.. (2009). Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency. PubMed. 3. 1–1. 2 indexed citations

9.

Gaspar, Bobby. (2009). Pegademase bovine (PEG-ADA) for the treatment of infants and children with severe combined immunodeficiency (SCID. Biologics. 349–349. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact